Physician profile
Michael Ha Sultan
NPI 1538505326
$5,281.78
in general payments reported to CMS, 2019-2025
22 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,416 · 2020: $834 · 2021: $334 · 2022: $679 · 2023: $544 · 2024: $181 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,640.78 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $725.02 | 2019-2020 | |
| Boston Scientific Corporation | $519.40 | 2019-2023 | Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $374.14 | 2019-2022 | |
| Abbott Laboratories | $311.68 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $212.23 | 2020 | |
| Medtronic, INC. | $168.00 | 2024-2025 | Symplicity G3, Azure Xt Dr Mri Surescan |
| Philips North America LLC | $159.12 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $156.29 | 2019-2020 | |
| Penumbra, INC. | $155.20 | 2022 | |
| Impulse Dynamics (USA) INC. | $151.86 | 2025 | Optimizer |
| Shockwave Medical, INC | $127.43 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Acist Medical Systems, INC. | $126.78 | 2019 | |
| Terumo Medical Corporation | $113.76 | 2019 | |
| Teleflex LLC | $110.80 | 2019-2023 | Turnpike |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $73.17 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.94 | 2019-2020 | |
| Pfizer INC. | $31.91 | 2023-2025 | |
| Chiesi USA, INC. | $19.20 | 2022 | |
| Cardiovascular Systems INC. | $15.99 | 2020 | |
| Biosense Webster, INC. | $15.36 | 2019 | |
| W. L. Gore & Associates, INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sultan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.